One study also identified iron chelators as useful adjunctive therapies in the treatment of COVID-19, such as deferasirox, desferrioxamine and deferiprone, as well as the naturally occurring iron chelator lactoferrin, which may be beneficial in combating COVID-19 disease progression (Perricone et al., 2020). The gene discussed is LTF; the disease is COVID-19.